On June 18th, 2020, Shift Health’s President, Dr. Ryan Wiley, joined Impetus Digital’s Managing Director, Natalie Yeadon, to discuss our progress towards the digitization of healthcare and how COVID-19 is setting the stage for a future-proofed data ecosystem.
News
Shift Health and Life Sciences Ontario Convene a Virtual Roundtable on the Impact of COVID-19 on Health Research and Innovation
Shift Health, in collaboration with LSO, convened a diverse panel of leaders to discuss what COVID-19 is teaching us and how we can prepare our health research and innovation ecosystem for a resilient and productive future.
Shift Health Releases Report Highlighting the Impacts of COVID-19 on the Future of Health Research and Innovation
COVID19 is altering—perhaps irreversibly—the health research and innovation ecosystem by compressing into mere weeks structural and system-level adaptations that might otherwise have evolved over a multi-year, or even generational, timescale.
Shift Health Publishes Commentary on COVID-19 and Health Data Ecosystem Challenges
We are proud to have partnered with Research Canada on a commentary for the Canadian Science Policy Centre.
PROVA Innovations wins $5,000 in consulting support from Shift Health
For the 6th year in a row, Shift Health was proud to be a partner of Innovation Factory’s annual Synapse Life Science Pitch Competition, awarding $5,000 of strategy consulting services to the runner-up, PROVA Innovations.
Shift Health Convenes Workshop on Future of Personalized Healthcare in Canada
Shift Health recently hosted a workshop to co-create Canada’s Personalized Healthcare Readiness Index.
Report from LSO 2019 Policy Forum Now Available
Life Sciences Ontario (LSO) has released proceedings from the LSO 2019 Annual Policy Forum.
Shift Health President Ryan Wiley Receives Research Canada Leadership in Advocacy Award
Dr. Ryan Wiley received the 2019 Research Canada Leadership in Advocacy Award.
Shift Health-Led Study Finds That Reported Costs of Alzheimer’s Disease Are the “Tip of the Iceberg”
A new research review suggests that traditional measures only show the ‘tip of the iceberg’ of the cost impact of Alzheimer’s on society.